Cell Therapy Research and Process Development
PBS Biotech has unmatched knowledge and experience across a broad spectrum of cell therapy bioprocesses such as:
- Mesenchymal stem cells & primary cells such as human chondrocytes, grown on suspended microcarriers
- Induced pluripotent & embryonic stem cells, grown as aggregates and differentiated into target cells
- Natural killer & T-cells, grown as loose clumps or single-cell suspensions
- Secretome production
We believe that the rapidly emerging cell therapy sector is the next big frontier of the biotech industry. However, the sensitivity of cell therapy products to growth conditions during scale-up make developing robust and scalable manufacturing processes very challenging. The combination of PBS Biotech's unique, low-shear, and scalable bioreactor technology and our cell therapy research experience makes us the ideal partner to help you develop your manufacturing process and get your product to market as quickly and efficiently as possible.